INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← Gut Microbiome / Health Desk

Almonds increased fecal butyrate—not gut transit speed

A four-week trial found a metabolite change alongside several unchanged gut outcomes.

Whole-food ingredients prepared without added oil

Illustrative food image, not a photograph of the study intervention.

A snack substitution, not an add-on cure

The almond trial enrolled 87 healthy adults and assigned them to whole almonds, ground almonds, or an isocaloric control for four weeks. Both almond groups received 56 g per day in place of habitual snacks. The primary outcome was fecal bifidobacteria, rather than constipation relief or prevention of disease. Researchers also measured microbial composition and diversity, short-chain fatty acids, gut transit, stool output, and symptoms. This design makes the comparison specific: it concerns replacing snacks under a short research protocol in healthy adults. It does not directly answer whether almonds treat a diagnosed bowel disorder or improve long-term clinical outcomes.

Creedon AC, Dimidi E, Hung ES, Rossi M et al.. The American journal of clinical nutrition, 2022. PMID 36130222 · DOI

The primary microbial outcome did not improve

The modified intention-to-treat analysis included 79 participants. Mean fecal bifidobacteria abundance was 8.7% after whole almonds, 7.8% after ground almonds, and 13.0% after the control intervention. The groups did not differ significantly on this primary outcome; the reported q value was 0.613. There was also no almond effect on microbiota diversity or composition at the phylum level. These null results belong beside any positive headline. The trial does not support describing almonds as a proven way to increase bifidobacteria, and it offers no basis for assuming that a food must raise microbial diversity to change another measured gut endpoint.

Creedon AC, Dimidi E, Hung ES, Rossi M et al.. The American journal of clinical nutrition, 2022. PMID 36130222 · DOI

Butyrate changed while transit did not

When the whole and ground almond groups were pooled, mean fecal butyrate was 24.1 micromoles per gram, compared with 18.2 in the control group, with P=.046. This was a metabolite measurement in stool, not a clinical disease outcome. Almond consumption did not affect gut transit time, stool consistency, or gut symptoms in the trial. The useful distinction is between a measurable change in one fermentation-related readout and an established improvement in bowel function. The abstract supports the former while reporting no effect on several physiological and symptom outcomes. A butyrate headline should therefore not become a promise of faster transit.

Creedon AC, Dimidi E, Hung ES, Rossi M et al.. The American journal of clinical nutrition, 2022. PMID 36130222 · DOI

Grinding changed particles, not the main outcomes

The study also investigated almond form. In the mastication work involving 31 participants, ground almonds produced smaller particle-size distributions and higher predicted lipid release than whole almonds. Predicted release averaged 10.4% with ground almonds and 9.3% with whole almonds, with P=.017. Yet almond form did not affect the trial's study outcomes. A physical difference after chewing therefore did not establish superior gut effects for ground almonds. Together with the four-week duration and healthy study population, this limits what can be inferred for everyday digestive symptoms. The evidence is more precise than a blanket claim that one almond texture is better for the gut.

Creedon AC, Dimidi E, Hung ES, Rossi M et al.. The American journal of clinical nutrition, 2022. PMID 36130222 · DOI